Roche/454 Genome Sequencer FLX Titanium (GS FLX Titanium)
The high throughput 454/GS FLX Titanium sequencing technology enables the identification of up to one million nucleid acid sequences with a length of 200 to 400 bp. Therefore, this sequencing technology is commonly used for de-novo whole genome sequencing, resequencing and Amplicon sequencing in significantly less time and at lower costs per base than the common Sanger sequencing technique.
Performance and advantages
- sequence up to 16 independent samples in one run (up to 192 independent samples by using MID-tags)
- sequence ~400 Mb in less than ten hours
- read length 200-400 bp
- ~1 million high quality reads per run (depending on the application)
- single base read accuracy >99%
- consensus accuracy >99.99%
Applications for the 454/GS FLX technology
Whole genome sequencing (de novo, resequencing) »...
- Shotgun Sequencing (bacteria, viruses)
- BAC-based Shotgun Sequencing (animals, plants)
Transcriptome analysis »...
- EST sequencing
- Genome identification sequencing (GIS-PET)
Gene regulation studies »...
- Identification of protein binding sites
- Analysis of DNA methylation patterns
Amplicon sequencing »...
Sequence based karyotyping »...
- Identification of copy number variations
- Detection of SNPs, Inserts, Deletions
Metagenomics »...
Further details concerning the Roche/454 GS FLX Titanium sequencing can also be obtained from the Roche/454 web site and the list of puplications.
You provide
- genomic samples: 100 µl genomic DNA dissolved in TE with a DNA concentration of at least 50 ng/µl (Nanodrop)
- Amplicons: 30 µl of your probe dissolved in TE with a DNA concentration of more than 25ng/µl (Nanodrop) (» Amplicon Primer Sequences)
You receive
- QC data and run statistics
- complete raw sequence (FASTA format) and quality data (additional files such as raw sff-files are also available)
- mapping, assembly and amplicon analysis data and statistics
- bioinformatics support for further analysis
For more information and experimental setup please contact us directly (Dr. Stephan Wolf).